Please tell us what you thought about today’s presentation by taking the survey below:
Sleep disturbance is a predominant symptom associated with depression, impacting ~75% of those diagnosed with depression. Insomnia, hypersomnia, and obstructive sleep apnea are all highly prevalent among those with depression.1 An estimated 40% of individuals among the general and healthcare populations have reported sleep problems because of the COVID pandemic, with certain gender and ethnic groups being impacted at a disproportionate rate.2 Given the positive correlation between sleep disturbances and depression, this has raised concerns among experts for the potential development of mood disorders more broadly across our society.
In this webinar, Dr. Beth DiNapoli moderates an enlightening discussion on the current state of the science in sleep and depression with experts in psychiatry and sleep, Drs. Vladimir Maletic and Marie Anne Gebara. They will reflect on scientific advances in understanding the complex, bidirectional relationship between sleep disturbances and depression, as well as the potential long-term impact of the SARS-CoV-2 pandemic on sleep quality and mood disorders. Educational and supportive resources for improving sleep hygiene will be provided. Join us for this unique opportunity to learn and grow as we all strive to improve our quality of life in this para-pandemic world!
References:
Vladimir Maletic, MD
Serves as Clinical Professor, Psychiatry/Behavioral Science, University of South Carolina School of Medicine Greenville, SC
Marie Anne Gebara, MD
Assistant Professor of Psychiatry, University of Pittsburgh
Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
Vladimir Maletic, MD, MS and Marie Anne Gebara, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Beth DiNapoli, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Notifications
